Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.
These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antipsychotic Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antipsychotic Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Antipsychotic Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline
Eli Lilly
Actavis Generics
Bristol-Myers Squibb
Alkermes
Johnson & Johnson
AstraZeneca
By Type:
First Antipsychotic Drugs
Second Antipsychotic Drugs
Third Antipsychotic Drugs
By End-User:
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antipsychotic Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Antipsychotic Drugs Market Size and Growth Rate of First Antipsychotic Drugs from 2016 to 2027
-
1.3.2 USA Antipsychotic Drugs Market Size and Growth Rate of Second Antipsychotic Drugs from 2016 to 2027
-
1.3.3 USA Antipsychotic Drugs Market Size and Growth Rate of Third Antipsychotic Drugs from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Antipsychotic Drugs Market Size and Growth Rate of Schizophrenia from 2016 to 2027
-
1.4.2 USA Antipsychotic Drugs Market Size and Growth Rate of Bipolar Disorder from 2016 to 2027
-
1.4.3 USA Antipsychotic Drugs Market Size and Growth Rate of Unipolar Depression from 2016 to 2027
-
1.4.4 USA Antipsychotic Drugs Market Size and Growth Rate of Dementia from 2016 to 2027
-
1.4.5 USA Antipsychotic Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Antipsychotic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Antipsychotic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Antipsychotic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Antipsychotic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antipsychotic Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antipsychotic Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of First Antipsychotic Drugs
-
3.4.2 Market Size and Growth Rate of Second Antipsychotic Drugs
-
3.4.3 Market Size and Growth Rate of Third Antipsychotic Drugs
4 Segmentation of Antipsychotic Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antipsychotic Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antipsychotic Drugs in Schizophrenia
-
4.4.2 Market Size and Growth Rate of Antipsychotic Drugs in Bipolar Disorder
-
4.4.3 Market Size and Growth Rate of Antipsychotic Drugs in Unipolar Depression
-
4.4.4 Market Size and Growth Rate of Antipsychotic Drugs in Dementia
-
4.4.5 Market Size and Growth Rate of Antipsychotic Drugs in Others
5 Market Analysis by Regions
-
5.1 USA Antipsychotic Drugs Production Analysis by Regions
-
5.2 USA Antipsychotic Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Antipsychotic Drugs Landscape Analysis
-
6.1 West USA Antipsychotic Drugs Landscape Analysis by Major Types
-
6.2 West USA Antipsychotic Drugs Landscape Analysis by Major End-Users
7 South USA Antipsychotic Drugs Landscape Analysis
-
7.1 South USA Antipsychotic Drugs Landscape Analysis by Major Types
-
7.2 South USA Antipsychotic Drugs Landscape Analysis by Major End-Users
8 Middle West USA Antipsychotic Drugs Landscape Analysis
-
8.1 Middle West USA Antipsychotic Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Antipsychotic Drugs Landscape Analysis by Major End-Users
9 Northeast USA Antipsychotic Drugs Landscape Analysis
-
9.1 Northeast USA Antipsychotic Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Antipsychotic Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 GlaxoSmithKline
-
10.1.1 GlaxoSmithKline Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Eli Lilly
-
10.2.1 Eli Lilly Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Actavis Generics
-
10.3.1 Actavis Generics Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Bristol-Myers Squibb
-
10.4.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Alkermes
-
10.5.1 Alkermes Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Johnson & Johnson
-
10.6.1 Johnson & Johnson Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 AstraZeneca
-
10.7.1 AstraZeneca Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Antipsychotic Drugs Market Size and Growth Rate of First Antipsychotic Drugs from 2016 to 2027
-
Figure USA Antipsychotic Drugs Market Size and Growth Rate of Second Antipsychotic Drugs from 2016 to 2027
-
Figure USA Antipsychotic Drugs Market Size and Growth Rate of Third Antipsychotic Drugs from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Antipsychotic Drugs Market Size and Growth Rate of Schizophrenia from 2016 to 2027
-
Figure USA Antipsychotic Drugs Market Size and Growth Rate of Bipolar Disorder from 2016 to 2027
-
Figure USA Antipsychotic Drugs Market Size and Growth Rate of Unipolar Depression from 2016 to 2027
-
Figure USA Antipsychotic Drugs Market Size and Growth Rate of Dementia from 2016 to 2027
-
Figure USA Antipsychotic Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Antipsychotic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Antipsychotic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Antipsychotic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Antipsychotic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antipsychotic Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antipsychotic Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antipsychotic Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Antipsychotic Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of First Antipsychotic Drugs
-
Figure Market Size and Growth Rate of Second Antipsychotic Drugs
-
Figure Market Size and Growth Rate of Third Antipsychotic Drugs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antipsychotic Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antipsychotic Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Schizophrenia
-
Figure Market Size and Growth Rate of Bipolar Disorder
-
Figure Market Size and Growth Rate of Unipolar Depression
-
Figure Market Size and Growth Rate of Dementia
-
Figure Market Size and Growth Rate of Others
-
Table USA Antipsychotic Drugs Production by Regions
-
Table USA Antipsychotic Drugs Production Share by Regions
-
Figure USA Antipsychotic Drugs Production Share by Regions in 2016
-
Figure USA Antipsychotic Drugs Production Share by Regions in 2021
-
Figure USA Antipsychotic Drugs Production Share by Regions in 2027
-
Table USA Antipsychotic Drugs Consumption by Regions
-
Table USA Antipsychotic Drugs Consumption Share by Regions
-
Figure USA Antipsychotic Drugs Consumption Share by Regions in 2016
-
Figure USA Antipsychotic Drugs Consumption Share by Regions in 2021
-
Figure USA Antipsychotic Drugs Consumption Share by Regions in 2027
-
Table West USA Antipsychotic Drugs Consumption by Types from 2016 to 2027
-
Table West USA Antipsychotic Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Antipsychotic Drugs Consumption Share by Types in 2016
-
Figure West USA Antipsychotic Drugs Consumption Share by Types in 2021
-
Figure West USA Antipsychotic Drugs Consumption Share by Types in 2027
-
Table West USA Antipsychotic Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Antipsychotic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Antipsychotic Drugs Consumption Share by End-Users in 2016
-
Figure West USA Antipsychotic Drugs Consumption Share by End-Users in 2021
-
Figure West USA Antipsychotic Drugs Consumption Share by End-Users in 2027
-
Table South USA Antipsychotic Drugs Consumption by Types from 2016 to 2027
-
Table South USA Antipsychotic Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Antipsychotic Drugs Consumption Share by Types in 2016
-
Figure South USA Antipsychotic Drugs Consumption Share by Types in 2021
-
Figure South USA Antipsychotic Drugs Consumption Share by Types in 2027
-
Table South USA Antipsychotic Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Antipsychotic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Antipsychotic Drugs Consumption Share by End-Users in 2016
-
Figure South USA Antipsychotic Drugs Consumption Share by End-Users in 2021
-
Figure South USA Antipsychotic Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Antipsychotic Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Antipsychotic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Antipsychotic Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Antipsychotic Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Antipsychotic Drugs Consumption Share by Types in 2027
-
Table Middle West USA Antipsychotic Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Antipsychotic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Antipsychotic Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Antipsychotic Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Antipsychotic Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Antipsychotic Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Antipsychotic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Antipsychotic Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Antipsychotic Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Antipsychotic Drugs Consumption Share by Types in 2027
-
Table Northeast USA Antipsychotic Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Antipsychotic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Antipsychotic Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Antipsychotic Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Antipsychotic Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Actavis Generics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis Generics
-
Figure Sales and Growth Rate Analysis of Actavis Generics
-
Figure Revenue and Market Share Analysis of Actavis Generics
-
Table Product and Service Introduction of Actavis Generics
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Alkermes
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alkermes
-
Figure Sales and Growth Rate Analysis of Alkermes
-
Figure Revenue and Market Share Analysis of Alkermes
-
Table Product and Service Introduction of Alkermes
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
